HIV infection: A review of their inhibitors progression

2Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This article provides a comprehensive recap of research on the basis of HIV infection, which is broad in worldwide. Human immunodeficiency virus (HIV) attacks the body's immune system, which is spread through the exchange of body fluids and unprotected sexual contact. HIV is extremely widespread diseases and results from a combination of defects in receptors assays and enzymatic assays, either of which may predominate. There are 33.3 million people worldwide, who suffered with HIV infection. The current prevalence of HIV infection is 0.26% of the India's population and 0.8% in some countries. The present review gives a brief introduction to various stages, complications, therapeutic targets for receptors and enzymes and obtainable drugs which may activate or inhibit the receptors and enzymes responsible for causing AIDS.

Cite

CITATION STYLE

APA

Pandey, D., Chouhan, U., & Verma, N. (2017). HIV infection: A review of their inhibitors progression. Biomedical and Pharmacology Journal, 10(2), 749–758. https://doi.org/10.13005/bpj/1164

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free